The Critical Vector · Guideline Verification — Confirmed Accurate

Brain Death / Death by Neurologic Criteria: The Framework, Checked Line by Line

An 11-slide carousel walking through the full BD/DNC determination pathway — checked against the actual 2023 AAN/AAP/CNS/SCCM consensus guideline this account cites throughout.

Original post: definshock. This page is an independent third-party verification, not affiliated with or endorsed by the account.

Verdict on the source post: this is a rare, genuinely comprehensive case — every numeric threshold, every prerequisite, the apnea test targets, and the ancillary testing table check out exactly against the primary 2023 guideline this account cites by PMID. There's no correction to make here. What this audit adds is why one specific slide (ancillary testing) matters more than it might look: it reflects a genuine, easy-to-miss change from the prior 2010/2011 guidelines that many clinicians trained under the old standard may not know about.

The Primary Source, Confirmed

Every PMID cited across the carousel traces to the actual guideline and its companion papers — not approximated, not misattributed.

PMID cited	What it actually is
37821233	Greer DM, Kirschen MP, Lewis A, et al. Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Guideline: Report of the AAN Guidelines Subcommittee, AAP, CNS, and SCCM. Neurology. 2023;101(24):1112–1132. — the primary guideline itself.
37921516	Kirschen MP, Lewis A, Greer DM. The 2023 AAN/AAP/CNS/SCCM guidelines: what the critical care team needs to know. Companion clinical-application paper for the primary guideline.
32761206	Greer DM, Shemie SD, Lewis A, et al. The World Brain Death Project. JAMA. 2020;324(11):1078–1097 — the international consensus document the 2023 US guideline explicitly aligns with.

Prerequisites, Apnea Thresholds, and Confounder Clearance: All Confirmed

Every specific number in this carousel matches the guideline's actual recommendation statements.

Carousel claim	Guideline confirmation
Wait ≥24h after acute HIBI before evaluation	Matches the 2023 guideline's minimum observation period for adults after hypoxic-ischemic brain injury
Core temp ≥36°C required; rewarm ≥24h if ≤35.5°C	Matches; this raised the threshold from earlier, lower thresholds used in prior guidelines
SBP ≥100 AND MAP ≥75 mmHg	Matches exactly — confirmed against the guideline's hemodynamic prerequisite and its apnea-test abort criteria (SBP ≤100 or MAP ≤75 despite support = abort)
Apnea test targets: PaCO2 ≥60 AND ≥20 above baseline AND pH <7.30	Matches exactly, including the chronic-hypercapnia-with-unknown-baseline provision requiring an ancillary test
EtOH <80 mg/dL; pentobarbital <5 µg/mL or below assay detection	Consistent with the guideline's drug-clearance thresholds and its general principle of accounting for hypothermia, renal/hepatic dysfunction, age, and obesity in clearance timing

The Slide That Matters Most: Ancillary Testing

This is genuinely new, and it's the single most important thing to internalize from this whole carousel if your training predates 2023.

EEG was removed as an acceptable ancillary test in 2023

Prior AAN (2010, adult) and AAP/CNS/SCCM (2011, pediatric) guidelines both listed EEG as an acceptable ancillary test for BD/DNC determination. The 2023 consensus guideline explicitly reclassified EEG as unacceptable, for all ages, aligning with the 2020 World Brain Death Project. The stated rationale: EEG assesses cerebral hemisphere function but doesn't evaluate the brainstem — and ancillary testing is typically needed precisely when brainstem function can't be fully assessed clinically, making a cortex-only test a poor fit for the actual clinical gap it's meant to fill. CT angiography and MR angiography remain unacceptable as they were before. The carousel's slide 9 states this correctly and concisely, but it's worth flagging explicitly: this is a genuine, substantive change from what many practicing clinicians were taught, not a restatement of longstanding practice.

The three tests the carousel lists as accepted — 4-vessel catheter angiography, radionuclide cerebral perfusion study, and transcranial Doppler ultrasonography — are exactly the three flow-based studies the 2023 guideline retains, all sharing the same underlying logic (confirming absence of cerebral blood flow) rather than assessing electrical or evoked activity.

The Rest of the Framework, Confirmed

Coma, brainstem areflexia, apnea as the three required findings — matches the guideline's core three-part definition exactly, including the "any preserved brain-mediated response or spontaneous breathing excludes BD/DNC" framing.
Spinal reflexes may persist and don't exclude BD/DNC — this is accurate and clinically important; triple flexion, deep tendon reflexes, and complex spinally-mediated movements are well-documented in the guideline and literature as compatible with a valid determination, provided the movement is confidently attributable to spinal, not brain-mediated, circuitry.
Minimum one adult examination under the 2023 guideline — correct; the guideline states two examinations provide additional certainty but one is sufficient in adults, while pediatric determination still requires two examinations and two apnea tests. The carousel's own follow-up comment correctly flags that state law and institutional policy may require more than the guideline minimum.
Ancillary testing cannot override a positive brain-mediated finding — this is exactly right and is one of the most important patient-safety points in the whole framework: ancillary tests exist to support a determination when the exam can't be completed, never to overrule a clinical exam finding of preserved function.

Bottom Line

This is thorough, accurate, well-sourced content on one of the highest-stakes determinations in medicine, and it holds up completely against the primary 2023 AAN/AAP/CNS/SCCM guideline it cites throughout by PMID. The account's own follow-up comment adds exactly the right caveats (chronic-hypercapnia baseline nuance, state-law variability on exam count, the fact that five half-lives isn't a guaranteed clearance rule in overdose/hypothermia/organ dysfunction) — this is a model example of how to do accurate, appropriately-hedged clinical education on a topic where getting it wrong has irreversible consequences. If there's one line to actually remember from this whole series, it's the EEG change: if your mental model of ancillary testing still includes EEG, that's the one thing in this entire framework worth actively updating.

Sources

definshock. Original Instagram carousel, "Brain Death: By the Book." — read the original post before relying on this summary.
Greer DM, Kirschen MP, Lewis A, et al. Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Guideline: Report of the AAN Guidelines Subcommittee, AAP, CNS, and SCCM. Neurology. 2023;101(24):1112–1132. doi:10.1212/WNL.0000000000207740. PMID: 37821233.
Lewis A, Kirschen MP, Greer DM. The 2023 AAN/AAP/CNS/SCCM Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Practice Guideline: A Comparison With the 2010 and 2011 Guidelines. Neurol Clin Pract. 2023;13(6):e200189.
Kirschen MP, Lewis A, Greer DM. The 2023 AAN/AAP/CNS/SCCM guidelines: what the critical care team needs to know. PMID: 37921516.
Greer DM, Shemie SD, Lewis A, et al. Determination of Brain Death/Death by Neurologic Criteria: The World Brain Death Project. JAMA. 2020;324(11):1078–1097. PMID: 32761206.
AAN Press Release. New Guidance Issued on the Determination of Brain Death. Oct 2023.